ASX 200 climbs on Friday as hearing implant company Cochlear slides amid lacklustre 2025 financial year result
The index grew 0.3 per cent in the first hour of trading.
Hearing implant maker Cochlear fell 2.2 per cent after it posted a nine per cent profit jump to $389m for the 2025 financial year.
It also revealed a five per cent increase in its full-year dividend to $4.30.
Despite the company's profit lifting, RBC Capital Markets analyst Craig Wong-Pan said the result was poor as it came in at the low end of the company's profit range.
"We expect the stock to underperform the market today," Mr Wong-Pan said.
Property developer Mirvac sank 1.5 per cent after revealing its revenue fell 10 per cent while packaging company Amcor crashed 10.4 per cent amid disappointment over its full year result.
Meanwhile, petrol company Ampol jumped 6.9 per cent after it announced a $1.1b acquisition of convenience store company EG Australia.
In the US, Bloomberg reported the Trump Administration is considering taking a stake in semiconductor manufacturer and designed Intel, boosting the company's share price about seven per cent.
On Thursday, the Dow Jones, Nasdaq and the S&P 500 all finished flat.
London's FTSE 250 sank 0.2 per cent while Germany's DAX rose 0.8 per cent and the STOXX Europe 600 added 0.6 per cent on Thursday.
New Zealand's NZX 50 grew 0.4 per cent while Japan's Nikkei 225 added 0.7 per cent since trading opened on Friday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
AU Financial Review
4 hours ago
- AU Financial Review
Dow lifts on UnitedHealth, consumer sentiment unexpectedly falls
The Dow Jones reset a record high, while both the S&P 500 and Nasdaq Composite slipped in the final trading session of the week in New York. UnitedHealth's shares leapt more than 10 per cent after Berkshire Hathaway lifted its stake in the health insurer. That helped the Dow offset weakness in Cisco, 3M and Goldman Sachs.
The Australian
4 hours ago
- The Australian
ASX hits fresh peak on Friday despite China's unexpected economic shift
Australia's sharemarket continued its strong gains, setting a new record high for the fifth straight session as a strong start to reporting season outweighed weakness out of China. The benchmark ASX200 continued its march higher during Friday afternoon's trading, closing up 64.80 points or 0.73 per cent to 8,938.60, while the broader All Ordinaries finished the day up 63 points or 0.69 per cent to 9,212.10. Australia's dollar also traded 0.13 per cent higher and at the time of writing was buying 65.03 US cents. In a broad market rally, nine of the 11 sectors traded higher with only consumer staples and technology finishing lower. Australia's sharemarket jumped during the afternoon's trading. Picture Newswire/ Gaye Gerard. The big four all gained, led by Westpac which jumped 2.14 per cent to $36.81 after announcing strong quarterly results on Thursday. ANZ also had a strong day up 1.78 per cent to $33.08, while NAB finished 0.80 per cent higher to $39.19 and Commonwealth Bank traded 0.57 per cent higher to $168.17. The materials sector helped lift the market with BHP shares up 1.08 per cent to $41.96, Rio Tinto jumped 1.41 per cent to $115.05 and Fortescue closed 1.28 per cent higher at $19.84. The rise in the materials sector came despite weakness out of China which could impact Australia's major resources sector. AMP chief economist and head of investment strategy Shane Oliver said Chinese economic data for July was soft. 'Retail sales, industrial production and investment all rose less than expected and residential property investment and sales are continuing to fall as are home prices,' Dr Oliver said. 'Unemployment rose slightly although this possibly due to grad and typhoon season.' The market ignored pressures from China, focusing on reporting season which so far has been better than expected. 'Results have been good with more upside than downside surprises, although most results have been in line, and a big increase in the number of companies reporting profits or dividends up on a year ago than in the December half reporting season,' Dr Oliver said. 'Just bear in mind though that it was much like this at the start of the last reporting season as there is a tendency for companies with good results to report early so results may soften over the next couple of weeks.' Nine of the 11 sectors gained. Picture: NewsWire / Damian Shaw He also said consensus earnings expectations are for overall business profits to fall 1.7 per cent. If the results show this, it would be the third year in a row corporate earnings shrunk. In company news, shares in hearing implant maker Cochlear gained 0.99 per cent to $309.03 after announcing a 1 per cent increase in underlying net profits to $392m, while revenue was up 4 per cent. Cochlear said it aimed to help more than 60,000 people to hear using one of its devices over the next year, up from 53,000 in the last financial year. Shares in Amcor sank 9.70 per cent to $13.60 after announcing its fourth-quarter results showing weakness out of its North American businesses. Baby Bunting soared 40.54 to $2.60 on its latest earnings with the business aiming to double its store network. According to its results until June 29 sales grew by 4.7 per cent to $521.9m, while margins increased and underlying net profit under tax soared 228 per cent to $12.1m. Read related topics: ASXChina Ties
Perth Now
8 hours ago
- Perth Now
Dow briefly hits record high on UnitedHealth's gains
The blue-chip Dow has briefly hit a record high, as UnitedHealth's shares jumped after Berkshire Hathaway raised its stake in the health insurer, while investors assessed mixed data to gauge the Federal Reserve's monetary policy path this year. UnitedHealth Group gained 11.6 per cent to hit a more than two-month high after Warren Buffett's company revealed a new investment in the health insurer, while Michael Burry's Scion Asset Management also turned more bullish on the company. Rising costs in the broader healthcare sector and an about 40 per cent slump in heavyweight UnitedHealth's shares this year have left the Dow lagging its Wall Street peers on the road to record highs. The price-weighted index last scaled an all-time high on December 4. This week, however, the healthcare sector is the top performer on the S&P 500 and is on track for its best weekly performance since October 2022. Other insurance stocks Centene and Molina gained 5.2 per cent each. A report showed retail sales in July rose as expected, but the University of Michigan's index tracking consumer confidence fell more than expected to 58 as inflation expectations rose. "As long as consumer spending holds up and companies are able to retain workers because of that robust spending, the flywheel can continue to spin, pushing corporate profits and stock prices higher," said Chris Zaccarelli, chief investment officer for Northlight Asset Management, speaking on the retail sales figures. In early trading on Friday, the Dow Jones Industrial Average rose 99.11 points, or 0.22 per cent, to 45,011.45, the S&P 500 lost 7.39 points, or 0.11 per cent, to 6,461.15 and the Nasdaq Composite lost 30.70 points, or 0.14 per cent, to 21,681.10. Wall Street's main US stock indexes are on track for their second week of gains, buoyed by expectations that the Fed could restart its monetary policy easing cycle with a 25-basis-point interest rate cut in September. The central bank last lowered borrowing costs in December and said US tariffs could add to price pressures. However, recent labour market weakness and signs that tariff-induced inflation was yet to reflect in headline consumer prices have made investors confident of a potential dovish move next month. Still, Chicago Fed President Austan Goolsbee said recent data reports showed a stagflationary impulse from tariffs on the economy. On the trade front, US President Donald Trump said he would unveil tariffs on steel and semiconductors next week. Applied Materials tumbled 11.3 per cent after the chip equipment maker issued weak fourth-quarter forecasts. Intel rose 3.0 per cent after a report said the Trump administration was in talks for the US government to potentially take a stake in the chipmaker. Attention was also on a meeting between Trump and Russian counterpart Vladimir Putin that markets hope could pave the way for a resolution to the Ukraine conflict. Declining issues outnumbered advancers by a 1.22-to-1 ratio on the NYSE and a 1.31-to-1 ratio on the Nasdaq. The S&P 500 posted 8 new 52-week highs and no new lows, while the Nasdaq Composite recorded 52 new highs and 45 new lows.
